Coya Therapeutics
Daniel Barvin, MBA has a diverse work experience. Daniel began their career in 2012 as a Design Engineer for MCFA. In 2013, they moved to GE Oil & Gas as a Product Engineer. From 2014 to 2017, they worked at Dril-Quip in two roles: Technical Sales Manager and Technical Sales Team Member. During this time, they also worked at Morgan Stanley as a Financial Advisor. In 2020, they volunteered at I AM ALS. Currently, they are working at Coya Therapeutics, Inc. as VP of Operations and Patient Advocacy and Director of Strategic Planning and Operations.
Daniel Barvin earned a B.S. in Mechanical Engineering from Case Western Reserve University between 2006 and 2010. Daniel then went on to earn a Master of Business Administration (MBA) from Rice Business - Jones Graduate School of Business between 2016 and 2018.
This person is not in any teams
Coya Therapeutics
1 followers
Coya is developing disruptive, first in class, autologous regulatory T-cell (Treg) and allogeneic exosome therapies - leveraging the seminal discoveries from the laboratory of Stanley Appel M.D., in which dysfunctional Tregs modulate neurodegenerative and autoimmune diseases.